Excited to share my work is published in HGG Advances! 🧬🖥️ Thankful to my mentors at Pfizer for the incredible opportunity. TL;DR We explore the interplay between rare pathogenic variants and common genetic modifiers of cardiomyopathy and provide an assessment of variant effect predictions.